Vax 2 Stop Cancer
- Assets
- $177.3k
- Revenue
- $236.8k
- Investments
- $0.0
- Employees
- 4
- Location
- Birmingham, AL
- Founding
- 01/2020
- Data as of
- 12/2023
- EIN
- 84-1758795
Organization Overview
Vax 2 Stop Cancer is located in Birmingham, AL. The organization was established in 2020. According to its NTEE Classification (E70) the organization is classified as: Public Health, under the broad grouping of Health Care and related organizations. As of 12/2023, Vax 2 Stop Cancer employed 4 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Vax 2 Stop Cancer is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Vax 2 Stop Cancer generated $236.8k in total revenue. This organization has experienced exceptional growth, as over the past 4 years, it has increased revenue by an average of 22.7% each year . All expenses for the organization totaled $176.6k during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
TO PREVENT CANCER BY EXPANDING THE USE OF THE HUMAN PAPILLOMAVIRUS (HPV) VACCINE THROUGH EDUCATION, PUBLIC AWARENESS, AND ADVOCACY.
Describe the Organization's Program Activity:
Part 3 - Line 4a
VAX 2 STOP CANCER TRAINS PEDIATRIC AND FAMILY MEDICINE PROVIDERS IN ALABAMA TO IMPROVE THEIR HPV VACCINATION RATE. SINCE OUR LAUNCH IN 2020, WE HAVE TRAINED 374 HEALTHCARE PROVIDERS AND STAFF AT 95 PRACTICES IN 31 ALABAMA COUNTIES WITH OUR HPV VACCINE PROVIDER EDUCATION PROGRAM TITLED PREVENTING HPV ASSOCIATED CANCERS THROUGH EFFECTIVE PROVIDER EDUCATION. IN TRAINING, PROVIDERS LEARN THE MOST EFFECTIVE METHOD FOR HPV VACCINE RECOMMENDATION STARTING AT AGE 9, RESEARCH-TESTED MESSAGING TO COUNSEL HESITANT PARENTS, AND STRATEGIES TO DECREASE MISSED OPPORTUNITIES TO GIVE THE VACCINE. VAX 2 STOP CANCER ALSO HAS A DENTAL PROVIDER EDUCATION PROGRAM. THE ONLINE PROGRAM TRAINS DENTISTS, PEDIATRIC DENTISTS, AND HYGIENISTS ON RECOMMENDING THE HPV VACCINE TO THEIR 9-26-YEAR-OLD PATIENTS. OROPHARYNGEAL CANCER IS NOW THE MOST FREQUENTLY DIAGNOSED HPV-ASSOCIATED CANCER, SURPASSING CERVICAL CANCER DIAGNOSES. HPV CAUSES 14,800 CASES OF OROPHARYNGEAL CANCER EACH YEAR IN THE US. THE HPV VACCINE RECOMMENDATION IS CRITICAL TO PREVENTING OROPHARYNGEAL CANCER AND ALL HPV CANCERS.BOTH OF THESE PROGRAMS UTILIZE METHODS ENDORSED BY THE NATIONAL CANCER INSTITUTE AND MATERIALS FROM THE UNIVERSITY OF NORTH CAROLINA AND THE NATIONAL HPV VACCINATION ROUNDTABLE. WE ALSO EDUCATE PARENTS, ADOLESCENTS, AND THE GENERAL PUBLIC ON THE SAFETY, EFFICACY, AND IMPORTANCE OF THE HPV VACCINE THROUGH OUR DIGITAL MEDIA PROGRAMS ON FACEBOOK, INSTAGRAM, TWITTER, LINKEDIN, AND TIKTOK.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
PDF Copies of 990 Filings
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Stuart A Lockwood DMD MPH Chair | OfficerTrustee | 1 | $0 |
Ginna White Vice Chair | OfficerTrustee | 1 | $0 |
Tamera Coyne-Beasley Mdmphfaapfsa Board Member | Trustee | 1 | $0 |
Philip Bryan Board Member | Trustee | 1 | $0 |
Casey L Danield PHD MPH Board Member | Trustee | 1 | $0 |
Leigh Anne Hodge JD Board Member | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $22,000 |
| Related organizations | $0 |
| Government grants | $25,000 |
| All other contributions, gifts, grants, and similar amounts not included above | $191,640 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $238,640 |
| Total Program Service Revenue | $0 |
| Investment income | $0 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | -$1,831 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $236,809 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $54,075 |
| Compensation of current officers, directors, key employees. | $5,408 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $61,156 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $10,735 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $870 |
| Fees for services: Accounting | $2,971 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $25,450 |
| Advertising and promotion | $5,308 |
| Office expenses | $9,120 |
| Information technology | $125 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $666 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $840 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $1,611 |
| All other expenses | $141 |
| Total functional expenses | $176,586 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $177,324 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $177,324 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $0 |
| Net assets without donor restrictions | $177,324 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $177,324 |